Repron therapeutics (private company)
See something wrong or missing? Let us know
Offices:Milano
Industry:
Health services
Pharma
Business model:
B2B
is an Italian health startup developing healthcare technology used to inhibit the activity of oncogenes on the basis of tumor malignancy through the use of engineered synthetic factors.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.18m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain
United Kingdom